277
Views
5
CrossRef citations to date
0
Altmetric
Sclera/Tenons

Comparing the Differences in Slowing Myopia Progression by Riboflavin/Ultraviolet A Scleral Cross-linking before and after Lens-induced Myopia in Guinea Pigs

, , , , , , & show all
Pages 531-539 | Received 06 Jun 2021, Accepted 20 Nov 2021, Published online: 22 Dec 2021
 

ABSTRACT

Purpose

To compare the effectiveness and differences in slowing myopia progression in Guinea pigs by riboflavin/ultraviolet A (UVA) scleral cross-linking (sCXL) before and after lens-induced myopia (LIM).

Methods

Forty 4-week-old Guinea pigs were randomly divided into four groups (n = 10 per group): CXL-A, CXL-B, LIM, and Control groups. The right eyes in CXL-A, CXL-B, LIM groups were treated with −10.00 D lenses from 4 to 10-week old and the left eyes were untreated. In CXL-A and CXL-B groups, riboflavin/UVA sCXL was performed on the right eyes at 4 weeks and 8 weeks of age, respectively. Both eyes were untreated in Control group. The intraocular pressure (IOP), the axial length (AXL), and the refraction were measured in vivo at 4, 8, and 10 weeks of age. At 10 weeks of age, the right eyes were enucleated for the tensile test and transmission electron microscopy observations.

Results

The myopia has been successfully induced in LIM and CXL-B groups during 4–8 weeks. In CXL-A group, the growth rate of AXL and myopic refraction was markedly inhibited during 4–8 weeks and the inhibitory effects diminished during 8–10 weeks. During 8–10 weeks, the growth rate of AXL and myopic refraction in CXL-B were marked suppressed. At 10 weeks of age, the myopia refraction was lower and the AXL was shorter in CXL-A group in comparison to CXL-B group. The IOP was not significantly different among the 4 groups of eyes at 4, 8, and 10 weeks of age. The scleral stiffness, the fibril diameters, and the fibril density of the sclera were significantly increased in CXL-A and CXL-B groups compared to LIM group.

Conclusion

Riboflavin/UVA sCXL administrated before and after the myopia modeling could both slow the myopia progression in Guinea pigs. The before-myopia preventative sCXL showed lower myopic refraction in the same age comparison between the cross-linked groups. The effect of riboflavin/UVA sCXL might reduce over time and the long-term effect should be further investigated. This sCXL intervention might control the ultrastructure alterations of the sclera during the myopia remodeling.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Ethical approval for animal experiments

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.

Author contributions

Conceptualization: Fengju Zhang

Data curation: Lingbo Lai, Xiaowei Wu

Formal analysis: Lingbo Lai, Xiaotong Lv, Yu Li, Mingshen Sun

Funding acquisition: Fengju Zhang

Investigation: Lingbo Lai, Xiaotong Lv, Yushan Xu, Zhe Chen

Methodology: Lingbo Lai, Xiaotong Lv, Yushan Xu, Zhe Chen

Project administration: Fengju Zhang

Additional information

Funding

This work was supported by the National Natural Science Foundation of China under Grant [81570877 and 81873682; http://www.nsfc.gov.cn/]; the 215 High-Level Talent Fund of Beijing Health Government under Grant [number 2013-2-023; http://www.bjchfp.gov.cn/]. and d were initially drawn by Reviewer 1 based on our data.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.